High-risk HPV present in subset of penile carcinomas

August 13, 2012
High-risk HPV present in subset of penile carcinomas
High-risk human papillomavirus infection is found in a subset of penile squamous cell carcinomas that may develop from undifferentiated penile intraepithelial neoplasia, according to a study published online Aug. 6 in the Journal of the American Academy of Dermatology.

(HealthDay) -- High-risk human papillomavirus (hrHPV) infection is found in a subset of penile squamous cell carcinomas (PSCCs) that may develop from undifferentiated penile intraepithelial neoplasia (PeIN), according to a study published online Aug. 6 in the Journal of the American Academy of Dermatology.

Carla Ferrándiz-Pulido, M.D., from the Hospital Universitari Vall d'Hebron in Barcelona, Spain, and colleagues examined the prevalence of HPV in a retrospective series of 82 patients with PSCC (69 invasive and 13 PeIN). Polymerase chain reaction assay with SPF-10 broad-spectrum primers followed by DNA enzyme immunoassay was used for HPV detection, and genotyping was performed using a reverse hybridization line probe assay.

The researchers identified HPV DNA in 31 of 77 (40.2 percent) PSCC cases (22 of 67 invasive and nine of 10 PeIN). HPV-16 was identified in 25 of 31 (80.6 percent) cases. Most basaloid and warty tumors were hrHPV positive, while only 15 percent of usual PSCC were hrHPV positive. All hrHPV-positive PSCC had an adjacent undifferentiated PeIN. The researchers found that hrHPV infection correlated with strong p16INK4a immunostaining, and p16INK4a immunohistochemical overexpression was present in most undifferentiated PeIN. There was better overall survival, although not statistically significant, in both hrHPV-positive and p16INK4a-positive tumors.

"In this study, we detected hrHPV in 28 percent of PSCC and in 90 percent of PeIN," the authors write. "These results allow identification of a subset of PSCC in which HPV would play a triggering role and give support to the bimodal etiopathogenic hypothesis that distinguishes two different subsets of PSCC."

Explore further: Study examines chronic inflammation in oral cavity and HPV status of head and neck cancers

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Study examines chronic inflammation in oral cavity and HPV status of head and neck cancers

June 18, 2012
Among patients with head and neck squamous cell carcinomas, a history of chronic inflammation in the mouth (periodontitis, i.e. gum disease) may be associated with an increased risk of tumors positive for human papillomavirus ...

Periodontitis linked to HPV-positive head, neck tumors

June 20, 2012
(HealthDay) -- For patients with head and neck squamous cell carcinoma (HNSCC) there is an increased risk of human papillomavirus (HPV)-positive tumors among those with a history of periodontitis, according to a study published ...

Prevalence of oral HPV infection higher among men than women

January 26, 2012
The overall prevalence of oral human papillomavirus (HPV) infection is approximately 7 percent among men and women ages 14 to 69 years in the United States, while the prevalence among men is higher than among women, according ...

HPV improves survival for African-Americans with throat cancer

July 19, 2012
Even though the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of survival, especially for African Americans with throat cancer, say Henry ...

Recommended for you

Study suggests colon cancer cells carry bacteria with them when they metastasize

November 24, 2017
(Medical Xpress)—A team of researchers working at Harvard University has found evidence that suggests a certain type of bacteria found in colon cancer tumors makes its way to tumors in other body parts by traveling with ...

Promising new treatment for rare pregnancy cancer leads to remission in patients

November 24, 2017
An immunotherapy drug can be used to cure women of a rare type of cancer arising from pregnancy when existing treatments have failed.

Researchers unravel novel mechanism by which tumors grow resistant to radiotherapy

November 23, 2017
A Ludwig Cancer Research study has uncovered a key mechanism by which tumors develop resistance to radiation therapy and shown how such resistance might be overcome with drugs that are currently under development. The discovery ...

African Americans face highest risk for multiple myeloma yet underrepresented in research

November 23, 2017
Though African-American men are three times more likely to be diagnosed with multiple myeloma, a type of blood cancer, most scientific research on the disease has been based on people of European descent, according to a study ...

Encouraging oxygen's assault on iron may offer new way to kill lung cancer cells

November 22, 2017
Blocking the action of a key protein frees oxygen to damage iron-dependent proteins in lung and breast cancer cells, slowing their growth and making them easier to kill. This is the implication of a study led by researchers ...

One-size treatment for blood cancer probably doesn't fit all, researchers say

November 22, 2017
Though African-American men are three times more likely to be diagnosed with a blood cancer called multiple myeloma, most scientific research on the disease has been based on people of European descent, according to a study ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.